P/E at 61.43 vs Industry's 59.56: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago

Share Via

A price-to-earnings ratio of 61.43 against an industry average of 59.56 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 13 Apr 2026. While the one-year return of 8.64% comfortably outpaces the Sensex’s decline of 2.97%, the stock’s recent momentum shows a more nuanced picture, with a 3-month gain of 14.28% contrasting with a near-flat daily performance. The data reveals a stock balancing valuation premium with steady performance across multiple timeframes.

Valuation Picture: Premium Reflecting Sector Confidence

Apollo Hospitals Enterprise Ltd. trades at a P/E of 61.43, slightly above the hospital industry’s average of 59.56. This premium, while not extreme, suggests investors are willing to pay a bit more for the company’s earnings relative to its peers. The market capitalisation stands at a substantial ₹1,11,760.22 crores, underscoring its large-cap status within the hospital sector. Such a valuation premium often reflects expectations of superior earnings growth or operational resilience, though it also raises questions about sustainability in a sector where margins can be pressured by regulatory and competitive factors. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside performance and technicals.

Performance Across Timeframes: Consistent Outperformance

Examining returns over various periods highlights Apollo Hospitals’s consistent outperformance relative to the Sensex. Over one year, the stock gained 8.64%, while the Sensex declined by 2.97%. Year-to-date, the stock is up 10.37% compared to the Sensex’s 9.14% loss. The three-month return is particularly notable at 14.28%, sharply contrasting with the Sensex’s negative 5.04%. Even over longer horizons, the stock’s performance is impressive: 76.53% over three years, 142.81% over five years, and a remarkable 471.25% over ten years, all well ahead of the Sensex’s respective 28.93%, 61.72%, and 199.67% gains. This sustained outperformance suggests a strong operational track record and market positioning. However, the stock’s daily change of 0.02% versus the Sensex’s -0.30% indicates a pause in momentum, raising the question is this a temporary consolidation or a sign of shifting sentiment?

Moving Average Configuration: Bullish Technical Setup

The technical picture for Apollo Hospitals is robust, with the stock trading above all key moving averages: 5-day, 20-day, 50-day, 100-day, and 200-day. This alignment indicates a strong upward trend and suggests that recent gains are supported by sustained buying interest. The stock is also just 3.43% away from its 52-week high of ₹8,099, signalling proximity to a significant resistance level. The two-day consecutive gain, delivering a 2.17% return, further confirms short-term strength. The 1-month return of 4.87% slightly outpaces the Sensex’s 4.54%, reinforcing the positive momentum. The 1-week gain of 0.96% against the Sensex’s 1.36% decline adds to the evidence of relative strength. The 5-day and 20-day moving averages acting as support levels may provide a cushion against short-term volatility — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — the moving average configuration provides the clearest answer.

Sector Context: Hospital Industry Performance

The hospital sector, within which Apollo Hospitals operates, has seen mixed results recently. While the industry P/E stands at 59.56, indicating a generally elevated valuation environment, sector performance has been varied with some companies facing margin pressures and regulatory challenges. Against this backdrop, Apollo Hospitals’s ability to maintain a premium valuation and deliver consistent returns is noteworthy. The stock’s outperformance relative to the Sensex and its sector peers suggests it remains a preferred choice within the hospital space. However, the sector’s overall mixed results highlight the importance of monitoring operational execution and regulatory developments closely.

Rating Context: Previously Rated Hold, Now Reassessed

On 13 Apr 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating by MarketsMOJO. The reassessment reflects a comprehensive analysis of valuation, performance, and technical factors. The current Mojo Score stands at 75.0, indicating a strong overall profile. This rating update invites investors to consider should investors in Apollo Hospitals hold, buy more, or reconsider? The current rating provides the answer.

Conclusion: Data Reflects a Balanced Valuation and Strong Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its industry peers, supported by consistent outperformance across short, medium, and long-term horizons. The technical setup is bullish, with the stock comfortably above all major moving averages and near its 52-week high. The sector’s mixed performance adds context to the valuation premium, suggesting that is this premium justified by operational strength or is it vulnerable to sector headwinds? The recent rating reassessment from Hold to a stronger stance reflects these nuanced factors, offering a comprehensive view for investors analysing this stock’s prospects.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE